Gene · 7804
Papers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,602
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic Landscape of Human Sperm in Patients with Different Spermatogenic Impairments. | Cells | 2023 | 37048090 | PubTator, text mining | PubMed |
| Multi-faceted role of LRP1 in the immune system. | Front Immunol | 2023 | 37020553 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquito. | PLoS Pathog | 2023 | 37018377 | PubTator, text mining | PubMed |
| Apolipoprotein E Recognizes Alzheimer's Disease Associated 3-O Sulfation of Heparan Sulfate. | Angew Chem Int Ed Engl | 2023 | 37014788 | PubTator, text mining | PubMed |
| Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events. | JAMA Netw Open | 2023 | 37014642 | PubTator, text mining | PubMed |
| Relationship of blood heavy metals and osteoporosis among the middle-aged and elderly adults: A secondary analysis from NHANES 2013 to 2014 and 2017 to 2018. | Front Public Health | 2023 | 36998274 | PubTator, text mining | PubMed |
| Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors. | Genes (Basel) | 2023 | 36980904 | PubTator, text mining | PubMed |
| Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond. | Curr Issues Mol Biol | 2023 | 36975494 | PubTator, text mining | PubMed |
| Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation. | Front Cardiovasc Med | 2023 | 36970356 | PubTator, text mining | PubMed |
| Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy. | Front Immunol | 2023 | 36969167 | PubTator, text mining | PubMed |
| The role and mechanism of action of tRNA-derived fragments in the diagnosis and treatment of malignant tumors. | Cell Commun Signal | 2023 | 36964534 | PubTator, text mining | PubMed |
| Associations between maternal and infant selenium status and child growth in a birth cohort from Dhaka, Bangladesh. | Br J Nutr | 2023 | 36944370 | PubTator, text mining | PubMed |
| Broad Host Tropism of Flaviviruses during the Entry Stage. | Microbiol Spectr | 2023 | 36943072 | PubTator, text mining | PubMed |
| Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation. | Front Immunol | 2023 | 36936925 | PubTator, text mining | PubMed |
| Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis. | Front Immunol | 2023 | 36911736 | PubTator, text mining | PubMed |
| Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action. | Molecules | 2023 | 36903551 | PubTator, text mining | PubMed |
| Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. | Nat Med | 2023 | 36879129 | PubTator, text mining | PubMed |
| Subtyping based on immune cell fractions reveal heterogeneity of cardiac fibrosis in end-stage heart failure. | Front Immunol | 2023 | 36875078 | PubTator, text mining | PubMed |
| The use of African medicinal plants in cancer management. | Front Pharmacol | 2023 | 36865913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7804/papers?page=12